Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Singular Genomics Systems Inc (NQ: OMIC )

21.50 +0.08 (+0.40%)
Streaming Delayed Price Updated: 11:15 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Singular Genomics Systems Inc

< Previous 1 2 Next >
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Announces 1-for-30 Reverse Stock Split
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Announces Participation in the UBS MedTech, Tools and Genomics Summit
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report Second Quarter 2023 Financial Results on August 9, 2023
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and First Quarter 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report First Quarter 2023 Financial Results on May 9, 2023
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Present at Cowen’s 43rd Annual Health Care Conference
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Launches Max Read™ Kits for Single Cell Sequencing on the G4 at AGBT
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT
The datasets are the latest to validate the performance and plug-and-play capability of the G4 across multiple applications 
From Singular Genomics Systems, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.